Prices delayed by at least 15 minutes | Print
Scancell Holdings PLC (SCLP)
ORD 0.1PThis share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Company profile
Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.
Address
Robert Robinson Avenue
John Eccles House, Oxford Science Park
Oxford
GBR
OX4 4GP
Telephone
+44 1865338069
Forecast key dates
Name | Key Date |
---|---|
Scancell Holdings PLC Second Quarter Earnings Results for 2025 | 2025-01-30T00:00:00 |
Scancell Holdings PLC Annual General Meeting for 2024 | 2024-11-29T14:00:00 |
Scancell Holdings PLC Annual Report for 2024 | 2024-10-31T00:00:00 |
Scancell Holdings PLC Fourth Quarter Earnings Results for 2024 | 2024-10-24T00:00:00 |
Previous key dates
Name | Key Date |
---|---|
Scancell Holdings PLC Second Quarter Earnings Results for 2024 | 2024-01-30T00:00:00 |
Scancell Holdings PLC Annual General Meeting for 2023 | 2023-11-29T14:00:00 |
Scancell Holdings PLC Annual Report for 2023 | 2023-10-31T00:00:00 |
Scancell Holdings PLC Fourth Quarter Earnings Results for 2023 | 2023-10-24T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.